Options Brief: AMAG Pharmaceuticals (AMAG)

Shares of AMAG Pharmaceuticals AMAG are lower on the session by 0.22%, trading at $18.19. Overall put volume is now running at 17.87x the daily average, with 6% of all puts traded being purchases on the offer. 3,752 contracts have traded on the session so far. AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease.